Abstract
Autoimmune diseases (AIDs) are chronic and multifactorial conditions resulting from the interaction between genetics, epigenetics, and environmental factors. The variety of these illnesses’ forms and presentations makes early detection of them difficult. To enable prompt intervention, biosensors have demonstrated efficacy in identifying biomarkers that signify the early stages of a disease. Biosensors have been developed since the first oxygen biosensor was invented in 1956, including wearable biosensors, which can monitor physiological parameters to detect autoimmune diseases early. Early detection is crucial to reducing mortality rates and minimizing the potential for disability, discomfort, drug reactions, and financial loss. Biosensors hold great promise for the future of autoimmune disease diagnosis and treatment, and the continued advancement and innovation in biosensor technology will increase the potential for early detection and prevention of autoimmune diseases. This paper reviews various types of biosensors for the detection and treatment of autoimmune diseases, highlighting their importance in the field and prospects for future development and application.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
